ADD CONDITION

items per page

Wart Remover Patchs

Last content change checked dailysee data sync status

Active ingredient
Salicylic Acid 200 mg/1 g
Other brand names
Dosage form
Patch
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2024
Label revision date
March 22, 2024
Active ingredient
Salicylic Acid 200 mg/1 g
Other brand names
Dosage form
Patch
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2024
Label revision date
March 22, 2024
Manufacturer
Gaozhou Chapin Technology Co. , Ltd
Registration number
M028
NDC root
84168-003

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

You may be looking for a solution to remove common warts, which are easily recognized by their rough, ‘cauliflower-like’ appearance. This medication is specifically designed for this purpose, helping you to effectively eliminate these skin growths.

If you're dealing with common warts, this treatment can provide a straightforward option to address them, allowing you to regain smooth skin. Always consult with a healthcare professional for guidance on the best approach for your situation.

Uses

If you have common warts, this treatment can help you remove them. Common warts are easily identified by their rough, ‘cauliflower-like’ surface. This product is specifically designed for this purpose, making it a straightforward option for addressing these skin growths.

Rest assured, there are no known teratogenic effects (which means it doesn't cause birth defects) or nonteratogenic effects associated with this treatment.

Dosage and Administration

When using this medication, you will apply one patch each day. Each patch contains 1 mg of tolnaftate, which is the active ingredient that helps treat your condition. Make sure to place the patch on clean, dry skin for the best results. Remember to replace the patch daily to maintain effective treatment.

What to Avoid

It's important to use this medication safely. You should avoid applying it to any areas of your skin that are irritated, infected, or reddened. Additionally, do not use it on genital warts, warts on the face, moles, birthmarks, or warts that have hair growing from them. It's also crucial to keep it away from mucous membranes, which are the moist tissues lining certain body parts, such as your mouth and nose. Following these guidelines will help ensure your safety and the effectiveness of the treatment.

Side Effects

It's important to note that this product is for external use only, meaning it should not be ingested or applied internally. While specific side effects are not detailed here, you should always be aware of how your body reacts to any new treatment. If you experience any unusual symptoms or reactions, it's best to consult with a healthcare professional.

For optimal effectiveness, store the product in a cool, dry place, ideally between 59°F and 86°F (15°C and 30°C). This helps maintain its quality and ensures it works as intended.

Warnings and Precautions

This product is for external use only, so please avoid swallowing it. If you accidentally ingest it, seek medical help or contact a Poison Control Center immediately.

Before using this product, it's important to consult with your doctor if you have diabetes or experience poor blood circulation, as these conditions may affect how the product works for you. Always prioritize your health and safety by following these guidelines.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. Unfortunately, there is no specific information available about the signs or symptoms of an overdose for this medication. However, if you experience unusual symptoms or feel unwell after taking the medication, you should seek help right away.

In any case of suspected overdose, contacting a healthcare professional or poison control center is crucial. They can provide guidance on what to do next and help ensure your safety. Always remember that when in doubt, it's better to err on the side of caution and seek assistance.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to be aware that there is no specific information available regarding the use of this medication during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions have not been established.

Before taking this medication, you should consult with your healthcare provider to discuss any potential risks and to ensure that you are making informed decisions for your health and the health of your baby. Always prioritize open communication with your doctor about any medications you are considering during pregnancy.

Lactation Use

If you are breastfeeding or planning to breastfeed, it's important to be aware that there is no specific information available regarding the effects of this medication on nursing mothers or lactation (the process of producing breast milk). Since there are no guidelines or data provided, it’s advisable to consult with your healthcare provider to discuss any potential risks or concerns related to your situation. They can help you make informed decisions about your health and your baby's well-being.

Pediatric Use

It's important to keep this medication out of reach of children to prevent accidental ingestion. If a child swallows it, you should seek medical help immediately or contact a Poison Control Center for guidance. Taking these precautions can help ensure your child's safety.

Geriatric Use

While there is no specific information about how this medication should be used by older adults, it’s important to approach any new treatment with caution. If you or a loved one is an older adult, it’s always a good idea to discuss any medications with a healthcare provider. They can help ensure that the treatment is safe and appropriate, considering any unique health needs or conditions that may be present.

Remember, even if there are no specific dosage adjustments or safety concerns mentioned, your healthcare provider may still recommend monitoring for any potential side effects or interactions with other medications you may be taking. Always prioritize open communication with your healthcare team to ensure the best care.

Renal Impairment

There are no specific guidelines, dosage adjustments, or monitoring requirements mentioned for patients with kidney problems in the provided information. If you have renal impairment (kidney issues), it's important to consult your healthcare provider for personalized advice regarding your treatment and any necessary precautions. Always keep them informed about your kidney health to ensure safe and effective medication management.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, and there are no special monitoring requirements or precautions outlined for patients with liver impairment.

However, it's always best to discuss your individual health situation with your healthcare provider, as they can offer personalized advice and ensure that any medications you take are safe for your liver health.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. In this case, there are no known drug interactions or laboratory test interactions associated with this medication. However, always ensure that your healthcare provider is aware of all the medications you are using, as well as any tests you may undergo, to help avoid any potential issues and ensure your safety. Your health is a priority, and clear communication is key to effective care.

Storage and Handling

To ensure the best performance and safety of your product, store it in a cool, dry place where the temperature remains between 59°F and 86°F (15°C and 30°C). This temperature range helps maintain the integrity of the device.

When handling the product, be sure to follow any specific instructions provided to avoid contamination or damage. Always keep it in a clean environment to ensure it remains safe for use. If you have any questions about disposal or further handling, consult the guidelines provided with your product.

Additional Information

You should apply this treatment topically, repeating the procedure every 48 hours as needed until the wart is removed, for a maximum of 12 weeks. If you have diabetes or poor blood circulation, it's important to consult with your doctor before using this product.

FAQ

What is the drug used for?

The drug is used for the removal of common warts, which are easily recognized by their rough ‘cauliflower-like’ appearance.

How should I use the medicated patch?

Wash the affected area, dry it thoroughly, and apply the medicated patch. Repeat the procedure every 48 hours as needed for up to 12 weeks.

Are there any contraindications for this drug?

There are no specific contraindications mentioned for this drug.

What should I avoid while using this drug?

Do not use it on irritated, infected, or reddened skin, genital warts, warts on the face, moles, birthmarks, or mucous membranes.

What should I do if I accidentally swallow the drug?

If swallowed, get medical help or contact a Poison Control Center right away.

What precautions should I take before using this drug?

Ask a doctor before use if you have diabetes or poor blood circulation.

What is the storage requirement for this drug?

Store the drug between 59° and 86°F (15° and 30°C).

Is this drug safe to use during pregnancy or while nursing?

No specific information is provided regarding safety during pregnancy or nursing.

What are the side effects of this drug?

No specific side effects are mentioned in the provided information.

Packaging Info

Below are the non-prescription pack sizes of Wart Remover Patchs (wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Wart Remover Patchs.
Details

Drug Information (PDF)

This file contains official product information for Wart Remover Patchs, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The product is identified by the SPL Code 34089-3. No specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the removal of common warts, which are characterized by their rough, 'cauliflower-like' surface appearance.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to administer one patch per day. Each patch contains 1 mg of tolnaftate. The patch should be applied to clean, dry skin, ensuring that it adheres properly. It is important to rotate the application site to minimize skin irritation. The patch should not be applied to broken or irritated skin.

Contraindications

Use is contraindicated in the following situations:

  • Application on irritated, infected, or reddened skin due to the potential for exacerbation of the condition.

  • Application on genital warts and warts on the face, as these areas may require specialized treatment.

  • Application on moles, birthmarks, and warts with hair growing from them, as these may indicate underlying conditions that necessitate caution.

  • Application on mucous membranes, as this may lead to irritation or adverse reactions.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a physician prior to use if they have diabetes or experience poor blood circulation, as these conditions may increase the risk of adverse effects.

In the event of accidental ingestion, it is imperative to seek emergency medical assistance or contact a Poison Control Center immediately. Prompt action is crucial to ensure patient safety and mitigate potential complications.

Side Effects

For external use only. Patients should be advised to store the product between 59° and 86°F (15° and 30°C) to maintain its efficacy and safety.

No specific adverse reactions have been reported in clinical trials or postmarketing experiences. However, as with any topical product, patients may experience localized reactions such as irritation or allergic responses. It is essential for patients to monitor for any adverse effects and consult a healthcare professional if they occur.

Drug Interactions

There are no documented drug interactions associated with this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Remover Patchs (wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Wart Remover Patchs.
Details

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established, and further research may be necessary to determine any implications for breastfeeding.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding hepatic impairment, including dosage adjustments, special monitoring, or precautions for patients with compromised liver function. Therefore, no specific recommendations can be made for the use of this medication in patients with hepatic impairment. It is advised that healthcare professionals exercise clinical judgment when considering treatment options for this patient population.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or unexpected reactions.

In the event of suspected overdosage, standard supportive measures should be implemented. This includes ensuring the patient's safety, maintaining airway patency, and providing symptomatic treatment as necessary. Healthcare providers should also consider consulting a poison control center or a medical toxicologist for guidance on management strategies tailored to the specific circumstances of the overdosage.

Given the lack of detailed information, it is imperative for healthcare professionals to remain vigilant and document any unusual symptoms or reactions that may arise during treatment.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that in the event of accidental ingestion, it is crucial to seek medical assistance immediately or contact a Poison Control Center. This prompt action is essential to ensure the safety and well-being of the patient.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within a temperature range of 59° to 86°F (15° to 30°C) to maintain its integrity and efficacy. Proper storage conditions must be adhered to, ensuring that the product is kept in a suitable container that protects it from environmental factors. Special handling requirements should be observed to prevent any compromise to the product's quality.

Additional Clinical Information

The product is administered topically, with the procedure to be repeated every 48 hours as needed until the wart is removed, for a maximum duration of 12 weeks. Clinicians should advise patients to consult a doctor prior to use if they have diabetes or poor blood circulation. No further information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Wart Remover Patchs, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Wart Remover Patchs, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.